| AEA | 2-AG | ||||||
---|---|---|---|---|---|---|---|---|
 | N | Average (pmol/ml) | SD | P-valuea | N | Average (pmol/ml) | SD | P-valuea |
FAAH promoter locus-variant | Â | Â | Â | 0.05 | Â | Â | Â | 0.10 |
   Carrier |  |  |  |  |  |  |  |  |
Cases | 14 | 17.11 | 5.79 | Â | 14 | 10.55 | 10.67 | Â |
Controls | 0 | NA | NA | Â | 0 | NA | NA | Â |
   Non-carrier |  |  |  |  |  |  |  |  |
Cases | 80 | 15.13 | 5.34 | Â | 67 | 5.63 | 3.04 | Â |
Controls | 48 | 13.76 | 5.51 | Â | 35 | 6.98 | 4.15 | Â |
MGLL intron 3 locus-variant | Â | Â | Â | 0.49 | Â | Â | Â | 0.80 |
   Carrier |  |  |  |  |  |  |  |  |
Cases | 5 | 15.6 | 6.35 | Â | 4 | 6.43 | 2.08 | Â |
Controls | 0 | NA | NA | Â | 0 | NA | NA | Â |
   Non-carrier |  |  |  |  |  |  |  |  |
Cases | 89 | 15.24 | 5.44 | Â | 77 | 6.49 | 5.57 | Â |
Controls | 48 | 13.76 | 5.52 | Â | 35 | 6.99 | 4.16 | Â |
MGLL promoter locus-variant | Â | Â | Â | 0.36 | Â | Â | Â | 0.37 |
   Carrier |  |  |  |  |  |  |  |  |
Cases | 26 | 15.09 | 5.6 | Â | 24 | 6.31 | 3.06 | Â |
Controls | 3 | 13.16 | 5.38 | Â | 3 | 4.41 | 4.46 | Â |
   Non-carrier |  |  |  |  |  |  |  |  |
Cases | 68 | 15.56 | 5.43 | Â | 57 | 6.56 | 6.2 | Â |
Controls | 45 | 13.8 | 5.58 | Â | 32 | 7.22 | 4.11 | Â |